Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma

NCT04500795 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04500795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Withdrawn
Start date
January 1, 2024
Completion date
March 31, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma, subdural hematoma